Cite
Analysis of current data on the use of topical rapamycin in the treatment of facial angiofibromas in tuberous sclerosis complex.
MLA
Balestri, R., et al. “Analysis of Current Data on the Use of Topical Rapamycin in the Treatment of Facial Angiofibromas in Tuberous Sclerosis Complex.” Journal of the European Academy of Dermatology and Venereology : JEADV, vol. 29, no. 1, Jan. 2015, pp. 14–20. EBSCOhost, https://doi.org/10.1111/jdv.12665.
APA
Balestri, R., Neri, I., Patrizi, A., Angileri, L., Ricci, L., & Magnano, M. (2015). Analysis of current data on the use of topical rapamycin in the treatment of facial angiofibromas in tuberous sclerosis complex. Journal of the European Academy of Dermatology and Venereology : JEADV, 29(1), 14–20. https://doi.org/10.1111/jdv.12665
Chicago
Balestri, R, I Neri, A Patrizi, L Angileri, L Ricci, and M Magnano. 2015. “Analysis of Current Data on the Use of Topical Rapamycin in the Treatment of Facial Angiofibromas in Tuberous Sclerosis Complex.” Journal of the European Academy of Dermatology and Venereology : JEADV 29 (1): 14–20. doi:10.1111/jdv.12665.